Congressional leaders look to reel in telehealth ads promoting drugs

Congressional leaders are calling for more oversight of telehealth company ads promoting prescription drugs without risk disclosures and for uses that aren’t FDA approved, The Wall Street Journal reported Jan. 19.

Leave a Comment

Your email address will not be published. Required fields are marked *